Prime Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	64.11	63.03	182.48	41.57	187.62	185.42
Short-Term Investments	71.39	114.65	7.97	80.09	106.3	84.2
Cash & Short-Term Investments	135.5	177.68	190.44	121.67	293.92	269.62
Cash Growth	-6.07%	-6.70%	56.53%	-58.61%	9.01%	405.59%
Other Current Assets	2.39	3.61	21.44	21.31	2.7	0.96
Total Current Assets	137.89	181.29	211.89	142.98	296.62	270.58
Net Property, Plant & Equipment	142.15	146.75	71.56	36.6	48.55	15.68
Other Long-Term Assets	14.69	14.69	14.06	14.28	15.14	15.6
Total Assets	294.73	342.73	297.51	193.85	360.31	301.86
Accounts Payable	12.33	8.89	11.35	19.54	4.33	1.44
Accrued Expenses	8.1	12.6	15.9	14.11	10.69	37.19
Current Portion of Leases	8.55	8.14	3.61	9.28	11.69	7.34
Unearned Revenue	7.32	7.82	7.09	-	-	-
Other Current Liabilities	-	-	-	13.5	-	12.02
Total Current Liabilities	36.29	37.45	37.96	56.42	26.71	57.98
Long-Term Leases	105.97	108.29	37.18	4.36	17.05	3.07
Other Long-Term Liabilities	75.78	76.13	69.22	-	0.28	1.24
Total Long-Term Liabilities	181.74	184.42	106.4	4.36	17.33	4.31
Total Liabilities	218.03	221.87	144.36	60.78	44.04	62.3
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	1,014	1,009	840.36	624.41	609.85	15.16
Accumulated Other Comprehensive Income	-0	0.08	0	-0.02	-0.38	-0.03
Retained Earnings	-937.48	-888.35	-687.21	-491.33	-293.2	-171.38
Total Common Shareholders' Equity	76.7	120.87	153.15	133.07	316.27	-156.24
Minority Interest	-	-	-	-	-	395.8
Shareholders' Equity	76.7	120.87	153.15	133.07	316.27	239.56
Total Liabilities & Equity	294.73	342.73	297.51	193.85	360.31	301.86
Total Debt	114.51	116.43	40.79	13.63	28.75	10.41
Net Cash (Debt)	20.99	61.25	149.65	108.03	265.18	259.21
Net Cash Growth	-65.74%	-59.07%	38.52%	-59.26%	2.30%	386.07%
Net Cash Per Share	0.13	0.41	1.26	1.19	7.82	19.98
Book Value	76.7	120.87	153.15	133.07	316.27	-156.24
Book Value Per Share	0.48	0.81	1.29	1.46	9.33	-12.04
Tangible Book Value	76.7	120.87	153.15	133.07	316.27	-156.24
Tangible Book Value Per Share	0.48	0.81	1.29	1.46	9.33	-12.04

SEC Filings: 10-K · 10-Q